EDDIT: Early Drug Discovery for Targeted Protein Degradation
ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.
Novel treatment for hypertrophic and keloidal scarring
A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies
Harnessing p53beta as a medical treatment of skin cancer
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
Innovative approach to treat ALS using a novel small molecule target
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Advancing a non-hallucinogenic psychedelic drug combination
D2B3 - Drug Delivery across the Blood Brain Barrier
